The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 17, 2015, Pages 2001-2009

  Kim, Yeon Mee ^a   Chaemsaithong, Piya ^b,c   Romero, Roberto ^b,d,e,i   Shaman, Majid ^b,c   Kim, Chong Jai ^b,f   Kim, Jung Sun ^b,g   Qureshi, Faisal ^b,c,h   Jacques, Suzanne M ^b,c,h   Ahmed, Ahmed I ^b,c   Chaiworapongsa, Tinnakorn ^b,c   Hassan, Sonia S ^b,c   Yeo, Lami ^b,c   Korzeniewski, Steven J ^b,c,e  

^a Inje University College of Medicine   (South Korea)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f University of Ulsan College of Medicine   (South Korea)

^g Sungkyunkwan University   (South Korea)

^h HARPER UNIVERSITY HOSPITAL   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; CD68; fibrinoid; foam cells; macrophage; spiral artery

Indexed keywords

ACUTE ATHEROSIS; ADULT; BIOPSY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PLACENTAL BED BIOPSY; PREECLAMPSIA; PREGNANCY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; ACUTE DISEASE; ARTERY; ATHEROSCLEROSIS; COHORT ANALYSIS; COMPLICATION; DECIDUA; FETAL MEMBRANES, PREMATURE RUPTURE; HYPERTENSION, PREGNANCY-INDUCED; OBSTETRIC LABOR, PREMATURE; PATHOLOGY; PLACENTA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; VASCULARIZATION;

ABORTION, SPONTANEOUS; ACUTE DISEASE; ARTERIES; ATHEROSCLEROSIS; BIOPSY; COHORT STUDIES; DECIDUA; FEMALE; FETAL DEATH; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, SMALL FOR GESTATIONAL AGE; OBSTETRIC LABOR, PREMATURE; PLACENTA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84942808903     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.976198     Document Type: Conference Paper

References (143)

1. Hertig AT. Vascular pathology in the hypertensive albuminuric toxemias of pregnancy. Clinics 1945;4:602-14.
2. Sexton LI, Hertig AT, Reid DE, et al. Premature separation of the normally im planted placenta; a clinicopathological study of 476 cases. Am J Obstet Gynecol 1950;59:13-24.
3. Zeek PM, Assali NS. Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol 1950; 20:1099-109.
4. Maqueo M, Chavezazuela J, Dosaldelavega M. Placental pathology in eclampsia and preeclampsia. Obstet Gynecol 1964;24:350-6.
5. Driscoll SG. The pathology of pregnancy complicated by diabetes mellitus. Med Clin North Am 1965;49:1053-67.
6. Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 1967;93:581-92.
7. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972;1:177-91.
8. Brosens I, Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaecol Br Commonw 1972;79:794-9.
9. Emmrich P, Birke R, Godel E. Morphology of myometrial and decidual arteries in normal pregnancy, in toxemia of pregnancy and in maternal diabetes (author's transl). Pathol Microbiol (Basel) 1975;43:38-61.
10. De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975; 123:164-74.
11. Robertson WB, Brosens I, Dixon G. Uteroplacental vascular pathology. Eur J Obstet Gynecol Reprod Biol 1975;5:47-65.
12. Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens 1976;5:115-27.
13. De Wolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980;87:678-85.
14. Abramowsky CR, Vegas ME, Swinehart G, et al. Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 1980;303:668-72.
15. Kitzmiller JL, Watt N, Driscoll SG. Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies. Am J Obstet Gynecol 1981;141:773-9.
16. Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981;88:695-705.
17. De Wolf F, Carreras LO, Moerman P, et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829-34.
18. Hustin J, Foidart JM, Lambotte R. Maternal vascular lesions in preeclampsia and intrauterine growth retardation: light microscopy and immunofluorescence. Placenta 1983;4::489-98.
19. Althabe O, Labarrere C, Telenta M. Maternal vascular lesions in placentae of small-for-gestational-age infants. Placenta 1985;6: 265-76.
20. Labarrere C, Alonso J, Manni J, et al. Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation. Am J Reprod Immunol Microbiol 1985;7:149-55.
21. Labarrere C, Althabe O. Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 1985;20:1-11.
22. Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-59.
23. McFadyen IR, Price AB, Geirsson RT. The relation of birthweight to histological appearances in vessels of the placental bed. Br J Obstet Gynaecol 1986;93:476-81.
24. Labarrere CA, Catoggio LJ, Mullen EG, et al. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol 1986;12:78-86.
25. Khong TY, Pearce JM, Robertson WB. Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion. Am J Obstet Gynecol 1987;157:360-3.
26. Labarrere CA. Acute atherosis. A histopathological hallmark of immune aggression? Placenta 1988;9:95-108.
27. Frusca T, Morassi L, Pecorelli S, et al. Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight. Br J Obstet Gynaecol 1989;96:835-9.
28. Khong TY. Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants and diabetes mellitus. Arch Pathol Lab Med 1991;115:722-5.
29. Meekins JW, Pijnenborg R, Hanssens M, et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669-74.
30. Meekins JW, Pijnenborg R, Hanssens M, et al. Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies. Placenta 1994;15:511-24.
31. Salafia CM, Parke AL. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum Dis Clin North Am 1997;23:85-97.
32. Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977;84: 656-63.
33. Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 1981;88:876-81.
34. Nayar R, Lage JM. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature. Hum Pathol 1996;27:201-6.
35. Hayati AR, Azizah A, Wahidah A. Incidence of acute atherosis in complete molar pregnancy. Malays J Pathol 1998;20:113-4.
36. Khong TY, Hague WM. The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol 1999;106:273-8.
37. Ogishima D, Matsumoto T, Nakamura Y, et al. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int 2000;50:224-9.
38. Sebire NJ, Rees H, Paradinas F, et al. Extravillus endovascular implantation site trophoblast invasion is abnormal in complete versus partial molar pregnancies. Placenta 2001;22:725-8.
39. Moldenhauer JS, Stanek J, Warshak C, et al. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003;189: 1173-7.
40. Faye-Petersen O, Heller DS, Joshi VV. Histologic lesions of the placenta: villi, fetal stem arteries, intervillous space and maternal arteries in decidua. In: Faye-Petersen O, Heller DS, Joshi VV, eds. Handbook of placental pathology. 2nd ed. United Kingdom: Taylor & Francis; 2006:53-78.
41. Harsem NK, Roald B, Braekke K, et al. Acute atherosis in decidual tissue: not associated with systemic oxidative stress in preeclampsia. Placenta 2007;28:958-64.
42. Fox H, Sebire NJ. Histological abnormalities of the placenta. In: Fox H, Sebire NJ, eds. Pathology of the placenta. 3rd ed. China: ELSEVIER; 2007:147-86.
43. Brosens I, Khong TY. Defective spiral artery remodeling. In: Pijnenborg R, Brosens I, Romero R, eds. Placental bed disorders. Cambridge, UK: Cambridge University Press; 2010:11.
44. Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: Acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 2010;56:1026-34.
45. Stevens DU, Al-Nasiry S, Bulten J, et al. Decidual vasculopathy in preeclampsia: lesion characteristics relate to disease severity and perinatal outcome. Placenta 2013;34:805-9.
46. Staff AC, Dechend R, Redman CW. Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: Two new hypotheses. Placenta 2013;34:S73-8.
47. Staff AC, Johnsen GM, Dechend R, et al. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol 2014;101-102:120-6.
48. Staff AC, Redman CW. IFPA award in placentology lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease. Placenta 2014;35:S26-31.
49. Mitchell RN. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol 2009;4:19-47.
50. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, Creactive protein, albumin or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279: 1477-82.
51. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
52. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14.
53. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009;27:165-97.
54. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:2045-51.
55. Khong TY, Liddell HS, Robertson WB. Defective haemochorial placentation as a cause of miscarriage: A preliminary study. Br J Obstet Gynaecol 1987;94:649-55.
56. Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 1992;99:651-4.
57. Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137-42.
58. Kim YM, Bujold E, Chaiworapongsa T, et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003;189:1063-9.
59. Ball E, Bulmer JN, Ayis S, et al. Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol 2006;208:535-42.
60. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006;27: 939-58.
61. Brosens I, Pijnenborg R, Vercruysse L, et al. The ''Great Obstetrical Syndromes'' are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193-201.
62. Pijnenborg R, Vercruysse L, Brosens I. Deep placentation. Best Pract Res Clin Obstet Gynaecol 2011;25:273-85.
63. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The calcium for preeclampsia prevention (CPEP) study group. Am J Obstet Gynecol 1997;177:1003-10.
64. Seeds JW. Impaired fetal growth: definition and clinical diagnosis. Obstet Gynecol 1984;64:303-10.
65. Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol 1996; 87:163-8.
66. Ogge G, Chaiworapongsa T, Romero R, et al. Placental lesions associated with maternal underperfusion are more frequent in earlyonset than in late-onset preeclampsia. J Perinat Med 2011;39: 641-52.
67. Espinoza J, Romero R, Mee Kim Y, et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006;34:447-58.
68. Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005;121:154-8.
69. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12: 642-9.
70. Hirashima C, Ohkuchi A, Matsubara S, et al. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res 2008;31: 1541-8.
71. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol 2010;63:534-43.
72. Hertig A, Fort J, Lefevre G, et al. Soluble endoglin in preeclamptic patients with or without HELLP syndrome. Am J Obstet Gynecol 2010;202:594. e1-4.
73. Boij R, Svensson J, Nilsson-Ekdahl K, et al. Biomarkers of coagulation, inflammation and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol 2012;68: 258-70.
74. Ozler A, Turgut A, Sak ME, et al. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur Rev Med Pharmacol Sci 2012;16: 1707-12.
75. Peracoli JC, Bannwart-Castro CF, Romao M, et al. High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early-from late-onset preeclampsia. J Reprod Immunol 2013;100:129-34.
76. Pinheiro MB, Martins-Filho OA, Mota AP, et al. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine 2013;62: 165-73.
77. Xiao JP, Yin YX, Gao YF, et al. The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia. Cytokine 2012;60:856-60.
78. Schonkeren D, van der Hoorn ML, Khedoe P, et al. Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am J Pathol 2011;178: 709-17.
79. Quinn KH, Lacoursiere DY, Cui L, et al. The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells. J Reprod Immunol 2011;91:76-82.
80. Kimura C, Watanabe K, Iwasaki A, et al. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Fetal Neonatal Med 2013;26:491-6.
81. Kvehaugen AS, Melien O, Holmen OL, et al. Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia. Hypertension 2013;61:655-61.
82. Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80-6.
83. Naccasha N, Gervasi MT, Chaiworapongsa T, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001;185:1118-23.
84. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114:409-14.
85. Watts DH, Krohn MA, Wener MH, et al. C-reactive protein in normal pregnancy. Obstet Gynecol 1991;77:176-80.
86. Gervasi MT, Chaiworapongsa T, Naccasha N, et al. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol 2001;185:1124-9.
87. Pitiphat W, Gillman MW, Joshipura KJ, et al. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005;162:1108-13.
88. Gotsch F, Romero R, Kusanovic JP, et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation and spontaneous parturition at term: A role for interleukin-10. J Matern Fetal Neonatal Med 2008;21: 529-47.
89. Kim MA, Lee BS, Park YW, et al. Serum markers for prediction of spontaneous preterm delivery in preterm labour. Eur J Clin Invest 2011;41:773-80.
90. Laudanski P, Raba G, Kuc P, et al. Assessment of the selected biochemical markers in predicting preterm labour. J Matern Fetal Neonatal Med 2012;25:2696-9.
91. Cruciani L, Romero R, Vaisbuch E, et al. Pentraxin 3 in maternal circulation: An association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010;23:1097-105.
92. Stampalija T, Chaiworapongsa T, Romero R, et al. Soluble ST2, a modulator of the inflammatory response, in preterm and term labor. J Matern Fetal Neonatal Med 2014;27:111-21.
93. Ismail MA, Zinaman MJ, Lowensohn RI, et al. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol 1985;151:541-4.
94. Yoon BH, Jun JK, Park KH, et al. Serum C-reactive protein, white blood cell count and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol 1996;88:1034-40.
95. Gervasi MT, Chaiworapongsa T, Naccasha N, et al. Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002;11:171-5.
96. Loukovaara MJ, Alfthan HV, Kurki MT, et al. Serum highly sensitive C-reactive protein in preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2003;110:26-8.
97. Moghaddam Banaem L, Mohamadi B, Asghari Jaafarabadi M, et al. Maternal serum C-reactive protein in early pregnancy and occurrence of preterm premature rupture of membranes and preterm birth. J Obstet Gynaecol Res 2012;38:780-6.
98. Gulati S, Agrawal S, Raghunandan C, et al. Maternal serum interleukin-6 and its association with clinicopathological infectious morbidity in preterm premature rupture of membranes: A prospective cohort study. J Matern Fetal Neonatal Med 2012;25: 1428-32.
99. Vince GS, Starkey PM, Austgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995;102:20-5.
100. Hamai Y, Fujii T, Yamashita T, et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997;38:89-93.
101. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40:102-11
102. Redman CW, Sacks GP, Sargent IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
103. Sabatier F, Bretelle F, D'Ercole C, et al. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction. Am J Obstet Gynecol 2000;183:1558-63.
104. Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001;185:792-7.
105. Teran E, Escudero C, Moya W, et al. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001;75:243-9.
106. Chaiworapongsa T, Romero R, Yoshimatsu J, et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med 2002;12:19-27.
107. Chaiworapongsa T, Gervasi MT, Refuerzo J, et al. Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia. Am J Obstet Gynecol 2002;187:889-93.
108. Velzing-Aarts FV, Muskiet FA, van der Dijs FP, et al. High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor. Am J Reprod Immunol 2002;48:319-22.
109. Serin IS, Ozcelik B, Basbug M, et al. Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2002;100:143-5.
110. Belo L, Santos-Silva A, Caslake M, et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy 2003;22:129-41.
111. Levine RJ, Qian C, Leshane ES, et al. Two-stage elevation of cellfree fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004;190:707-13.
112. Kocyigit Y, Atamer Y, Atamer A, et al. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 2004;19: 267-73.
113. Freeman DJ, McManus F, Brown EA, et al. Short-and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004;44:708-14.
114. Kim YM, Romero R, Oh SY, et al. Toll-like receptor 4: A potential link between ''danger signals, '' the innate immune system and preeclampsia? Am J Obstet Gynecol 2005;193:921-7.
115. Braekke K, Holthe MR, Harsem NK, et al. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Am J Obstet Gynecol 2005;193: 227-33.
116. Enquobahrie DA, Williams MA, Qiu C, et al. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women. J Matern Fetal Neonatal Med 2005;17:343-8.
117. Jonsson Y, Ruber M, Matthiesen L, et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006;70:83-91.
118. Kusanovic JP, Romero R, Hassan SS, et al. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med 2007;20:867-78.
119. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007;58:21-30.
120. Laskowska M, Laskowska K, Leszczynska-Gorzelak B, et al. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation. J Matern Fetal Neonatal Med 2007;20: 527-32.
121. Sibai B, Romero R, Klebanoff MA, et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol 2009;200:630. e1-8.
122. Ogge G, Romero R, Chaiworapongsa T, et al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med 2010;23:476-87.
123. Soto E, Romero R, Richani K, et al. Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products. J Matern Fetal Neonatal Med 2010;23: 646-57.
124. Szarka A, Rigo Jr J, Lazar L, et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010;11:59.
125. Xie C, Yao MZ, Liu JB, et al. A meta-analysis of tumor necrosis factor-alpha, interleukin-6 and interleukin-10 in preeclampsia. Cytokine 2011;56:550-9.
126. Twina G, Sheiner E, Shahaf G, et al. Lower circulation levels and activity of alpha-1 antitrypsin in pregnant women with severe preeclampsia. J Matern Fetal Neonatal Med 2012;25: 2667-70.
127. Stampalija T, Chaiworapongsa T, Romero R, et al. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med 2013;26: 1359-70.
128. Sahin S, Ozakpinar OB, Eroglu M, et al. The impact of platelet functions and inflammatory status on the severity of preeclampsia. J Matern Fetal Neonatal Med 2014. [Epub ahead of print].
129. Labarrere C, Manni J, Salas P, et al. Intrauterine growth retardation of unknown etiology. I. Serum complement and circulating immune complexes in mothers and infants. Am J Reprod Immunol Microbiol 1985;8:87-93.
130. Labarrere CA, Althabe OH. Intrauterine growth retardation of unknown etiology: II. Serum complement and circulating immune complexes in maternal sera and their relationship with parity and chronic villitis. Am J Reprod Immunol Microbiol 1986;12:4-6.
131. Johnston TA, Greer IA, Dawes J, et al. Neutrophil activation in small for gestational age pregnancies. Br J Obstet Gynaecol 1991; 98:105-6.
132. Johnson MR, Anim-Nyame N, Johnson P, et al. Does endothelial cell activation occur with intrauterine growth restriction? BJOG 2002;109:836-9.
133. Coata G, Pennacchi L, Bini V, et al. Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction. J Matern Fetal Neonatal Med 2002;12:28-34.
134. Tjoa ML, van Vugt JM, Go AT, et al. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003;59:29-37.
135. Cetin I, Cozzi V, Pasqualini F, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2006;194: 1347-53.
136. Girardi G, Yarilin D, Thurman JM, et al. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006;203: 2165-75.
137. Laskowska M, Laskowska K, Leszczynska-Gorzelak B, et al. Maternal and umbilical sTNF-R1 in preeclamptic pregnancies with intrauterine normal and growth retarded fetus. Hypertens Pregnancy 2007;26:13-21.
138. Erez O, Romero R, Hoppensteadt D, et al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med 2008;21:855-69.
139. Duff P. Pyelonephritis in pregnancy. Clin Obstet Gynecol 1984; 27:17-31.
140. Gilstrap 3rd LC, Lucas MJ. Urinary tract infections in women. Curr Opin Obstet Gynecol 1990;2:643-8.
141. Soto E, Richani K, Romero R, et al. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med 2005;17:247-52.
142. Kim YM, Romero R. Cover image. Am J Obstet Gynecol 2014;212.
143. Alnaes-Katjavivi P, Lyall F, Roald B, et al. Placenta 2013;34:A11 (abstract P1. 1).